# Siebert Financial Corp: financial statements, quarterly

SIEB · Nasdaq · CIK 65596 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sieb.md) · [Financials](/companies/sieb/financials.md) · [Filings](/companies/sieb/filings.md) · [Insiders](/companies/sieb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sieb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [18.1](/filings/0001213900-24-096271.md) | [19.7 d](/filings/0001213900-25-026597.md) | [20.5](/filings/0001213900-25-042693.md) | [20.9](/filings/0001213900-25-075082.md) | [22.6](/filings/0001213900-25-109356.md) | [20.0 d](/filings/0001213900-26-036500.md) | [28.9](/filings/0001213900-26-057679.md) | [14.9](/filings/0001213900-26-087833.md) | [26.8](/filings/0001213900-25-109356.md) | [23.6 d](/filings/0001213900-26-036500.md) | [23.5](/filings/0001213900-26-057679.md) | [31.2](/filings/0001213900-26-087833.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [4.3](/filings/0001213900-24-096271.md) | [4.9 d](/filings/0001213900-25-026597.md) | [5.1](/filings/0001213900-25-042693.md) | [5.6](/filings/0001213900-25-075082.md) | [4.8](/filings/0001213900-25-109356.md) | [1.9 d](/filings/0001213900-26-036500.md) | [10.5](/filings/0001213900-26-057679.md) | [(5.8)](/filings/0001213900-26-087833.md) | [2.2](/filings/0001213900-25-109356.md) | [(1.3) d](/filings/0001213900-26-036500.md) | [(2.9)](/filings/0001213900-26-057679.md) | [(0.5)](/filings/0001213900-26-087833.md) |
| Interest expense | $m | [0.0](/filings/0001213900-23-086806.md) | [0.0 d](/filings/0001213900-24-041746.md) | [0.1](/filings/0001213900-24-045813.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.5](/filings/0001213900-24-096271.md) | [(0.2) d](/filings/0001213900-25-026597.md) | [1.4](/filings/0001213900-25-042693.md) | [1.5](/filings/0001213900-25-075082.md) | [1.0](/filings/0001213900-25-109356.md) | [0.2 d](/filings/0001213900-26-036500.md) | [1.8](/filings/0001213900-26-057679.md) | [(1.1)](/filings/0001213900-26-087833.md) | [0.6](/filings/0001213900-25-109356.md) | [(0.8) d](/filings/0001213900-26-036500.md) | [(0.9)](/filings/0001213900-26-057679.md) | [(0.1)](/filings/0001213900-26-087833.md) |
| Net income | $m | [2.8](/filings/0001213900-23-086806.md) | [(0.8) d](/filings/0001213900-24-041746.md) | [3.7](/filings/0001213900-25-109356.md) | [4.0](/filings/0001213900-25-109356.md) | [3.8](/filings/0001213900-25-109356.md) | [1.7 d](/filings/0001213900-26-036500.md) | [8.7](/filings/0001213900-26-087833.md) | [(4.7)](/filings/0001213900-26-087833.md) | [1.6](/filings/0001213900-25-109356.md) | [(0.4) d](/filings/0001213900-26-036500.md) | [(2.0)](/filings/0001213900-26-087833.md) | [(0.3)](/filings/0001213900-26-087833.md) |
| Diluted EPS | $ per share | [0.07](/filings/0001213900-24-096271.md) | not reported | [0.09](/filings/0001213900-25-042693.md) | [0.10](/filings/0001213900-25-075082.md) | [0.10](/filings/0001213900-25-109356.md) | not reported | [0.22](/filings/0001213900-26-057679.md) | [(0.12)](/filings/0001213900-26-087833.md) | [0.04](/filings/0001213900-25-109356.md) | not reported | [(0.05)](/filings/0001213900-26-057679.md) | [(0.01)](/filings/0001213900-26-087833.md) |
| Basic EPS | $ per share | [0.07](/filings/0001213900-24-096271.md) | not reported | [0.09](/filings/0001213900-25-042693.md) | [0.10](/filings/0001213900-25-075082.md) | [0.10](/filings/0001213900-25-109356.md) | not reported | [0.22](/filings/0001213900-26-057679.md) | [(0.12)](/filings/0001213900-26-087833.md) | [0.04](/filings/0001213900-25-109356.md) | not reported | [(0.05)](/filings/0001213900-26-057679.md) | [(0.01)](/filings/0001213900-26-087833.md) |

- Revenue: us-gaap:Revenues
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [4.9](/filings/0001213900-24-096271.md) | [5.7](/filings/0001213900-25-026597.md) | [2.9](/filings/0001213900-25-042693.md) | [5.2](/filings/0001213900-25-075082.md) | [4.4](/filings/0001213900-25-109356.md) | [32.6](/filings/0001213900-26-036500.md) | [25.7](/filings/0001213900-26-057679.md) | [28.9](/filings/0001213900-26-087833.md) | [19.6](/filings/0001213900-25-109356.md) | [22.4](/filings/0001213900-26-087833.md) | [16.2](/filings/0001213900-26-057679.md) | [16.1](/filings/0001213900-26-087833.md) |
| Current assets | $m | [750](/filings/0001213900-23-086806.md) | [774](/filings/0001213900-25-026597.md) | [713](/filings/0001213900-24-045813.md) | [580](/filings/0001213900-24-068836.md) | [550](/filings/0001213900-24-096271.md) | [492](/filings/0001213900-26-036500.md) | [505](/filings/0001213900-25-042693.md) | [527](/filings/0001213900-25-075082.md) | [576](/filings/0001213900-25-109356.md) | [727](/filings/0001213900-26-087833.md) | [564](/filings/0001213900-26-057679.md) | [935](/filings/0001213900-26-087833.md) |
| Total assets | $m | [771](/filings/0001213900-23-086806.md) | [802](/filings/0001213900-25-026597.md) | [742](/filings/0001213900-24-045813.md) | [609](/filings/0001213900-24-068836.md) | [579](/filings/0001213900-24-096271.md) | [520](/filings/0001213900-26-036500.md) | [534](/filings/0001213900-25-042693.md) | [561](/filings/0001213900-25-075082.md) | [607](/filings/0001213900-25-109356.md) | [759](/filings/0001213900-26-087833.md) | [597](/filings/0001213900-26-057679.md) | [969](/filings/0001213900-26-087833.md) |
| Current liabilities | $m | [692](/filings/0001213900-23-086806.md) | [722](/filings/0001213900-25-026597.md) | [659](/filings/0001213900-24-045813.md) | [522](/filings/0001213900-24-068836.md) | [489](/filings/0001213900-24-096271.md) | [428](/filings/0001213900-26-036500.md) | [434](/filings/0001213900-25-042693.md) | [465](/filings/0001213900-25-075082.md) | [506](/filings/0001213900-25-109356.md) | [661](/filings/0001213900-26-087833.md) | [500](/filings/0001213900-26-057679.md) | [872](/filings/0001213900-26-087833.md) |
| Total liabilities | $m | [700](/filings/0001213900-23-086806.md) | [731](/filings/0001213900-25-026597.md) | [667](/filings/0001213900-24-045813.md) | [530](/filings/0001213900-24-068836.md) | [496](/filings/0001213900-24-096271.md) | [435](/filings/0001213900-26-036500.md) | [440](/filings/0001213900-25-042693.md) | [471](/filings/0001213900-25-075082.md) | [516](/filings/0001213900-25-109356.md) | [670](/filings/0001213900-26-087833.md) | [509](/filings/0001213900-26-057679.md) | [880](/filings/0001213900-26-087833.md) |
| Long-term debt | $m | [4.2](/filings/0001213900-23-086806.md) | [4.2](/filings/0001213900-25-026597.md) | [4.2](/filings/0001213900-24-045813.md) | [4.2](/filings/0001213900-24-068836.md) | [4.2](/filings/0001213900-24-096271.md) | [4.1](/filings/0001213900-26-036500.md) | [4.1](/filings/0001213900-25-042693.md) | [4.1](/filings/0001213900-25-075082.md) | [4.1](/filings/0001213900-25-109356.md) | [4.0](/filings/0001213900-26-087833.md) | [4.0](/filings/0001213900-26-057679.md) | [4.0](/filings/0001213900-26-087833.md) |
| Current portion of debt | $m | [0.1](/filings/0001213900-23-086806.md) | [0.1](/filings/0001213900-25-026597.md) | [0.1](/filings/0001213900-24-045813.md) | [0.1](/filings/0001213900-24-068836.md) | [0.1](/filings/0001213900-24-096271.md) | [0.5](/filings/0001213900-26-036500.md) | [0.1](/filings/0001213900-25-042693.md) | [0.1](/filings/0001213900-25-075082.md) | [1.0](/filings/0001213900-25-109356.md) | [1.0](/filings/0001213900-26-087833.md) | [1.0](/filings/0001213900-26-057679.md) | [1.0](/filings/0001213900-26-087833.md) |
| Shareholders' equity | $m | [70.6](/filings/0001213900-23-086806.md) | [69.7](/filings/0001213900-25-026597.md) | [73.8](/filings/0001213900-24-045813.md) | [78.2](/filings/0001213900-24-068836.md) | [82.3](/filings/0001213900-24-096271.md) | [84.1](/filings/0001213900-26-036500.md) | [93.3](/filings/0001213900-25-042693.md) | [89.0](/filings/0001213900-25-075082.md) | [90.9](/filings/0001213900-25-109356.md) | [89.2](/filings/0001213900-26-087833.md) | [88.1](/filings/0001213900-26-057679.md) | [88.7](/filings/0001213900-26-087833.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(19.4) d](/filings/0001213900-24-096271.md) | [64.2 d](/filings/0001213900-25-026597.md) | [(47.0)](/filings/0001213900-25-042693.md) | [18.6 d](/filings/0001213900-25-075082.md) | [3.0 d](/filings/0001213900-25-109356.md) | [35.5 d](/filings/0001213900-26-036500.md) | [(34.5)](/filings/0001213900-26-057679.md) | [0.6 d](/filings/0001213900-26-087833.md) | [43.7 d](/filings/0001213900-25-109356.md) | [0.4 d](/filings/0001213900-26-036500.md) | [(26.1)](/filings/0001213900-26-057679.md) | [(2.6) d](/filings/0001213900-26-087833.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001213900-24-096271.md) | [0.0 d](/filings/0001213900-25-026597.md) | [0.0](/filings/0001213900-25-042693.md) | [0.0 d](/filings/0001213900-25-075082.md) | [0.0 d](/filings/0001213900-25-109356.md) | [0.2 d](/filings/0001213900-26-036500.md) | [0.1](/filings/0001213900-26-057679.md) | [0.1 d](/filings/0001213900-26-087833.md) | [0.3 d](/filings/0001213900-25-109356.md) | [0.1 d](/filings/0001213900-26-036500.md) | [0.1](/filings/0001213900-26-057679.md) | [0.1 d](/filings/0001213900-26-087833.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [32.4](/filings/0001213900-23-086806.md) | [32.5](/filings/0001213900-24-045813.md) | [36.4](/filings/0001213900-24-068836.md) | [39.7](/filings/0001213900-24-096271.md) | [39.8](/filings/0001213900-25-042693.md) | [39.9](/filings/0001213900-25-075082.md) | [40.0](/filings/0001213900-25-109356.md) | [40.2](/filings/0001213900-26-057679.md) | [40.4](/filings/0001213900-26-087833.md) | [40.4](/filings/0001213900-25-109356.md) | [40.8](/filings/0001213900-26-057679.md) | [41.0](/filings/0001213900-26-087833.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 41,100,936 at 2026-08-11, from the cover of the [10-Q filed 2026-08-11](/filings/0001213900-26-087833.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.